Oral semaglutide, available at $289/mo (or $249/mo on the 6-month plan), is typically not recommended for cirrhotic patients because it requires stomach acid for absorption and hepatic processing of the oral formulation is less predictable in liver disease
Based on such findings, guideline-directed medical therapy currently recommends SGLT2 inhibitors for people with type 2 diabetes mellitus who are at risk for HF, have pre-HF, or have established HF [92]
This is especially important for patients with diabetes, high blood pressure, digestive concerns, thyroid history, medication interactions, prior pancreatitis concerns, or other medical issues
Hemoglobin is a protein in red blood cells that carries oxygen
The meeting is scheduled for July 23 and 24, 2026 and will be open to the public both in person and through an online teleconferencing platform